NCT06719284

Brief Summary

Mechanical ventilation (MV) is life saving for infants requiring respiratory support in the newborn period but its use has been associated with complications. High frequency oscillation (HFO) is a type of MV that delivers small volumes of gas across the lungs at fast frequencies. HFO is a lung protective strategy but it has also been linked to brain injury due to low carbon dioxide tensions. High-frequency oscillation with volume-targeted ventilation (HFO\&VTV) is a new mode of HFO in which the clinician sets a target volume of gas to be delivered to the lungs at fast rates to decrease the lung injury related to the ventilator. Further, HFO\&VTV achieves better control of carbon dioxide levels and may therefore protect against brain injury. Currently, there are no written guidelines about the use of HFO\&VTV. This study aim to determine the safety profile of HFO\&VTV compared to HFO by comparing the velocity of blood flow to the brain in term born infants and the cardiac output in term and preterm infants during the two modes. The investigators will also determine the optimum starting value of the target tidal volume during HFOV\&VTV. Infants will be studied at three different target tidal volumes for a period of 10-20 minutes each. A cranial ultrasound (for term infants only) and bedside echocardiogram will be performed at the end of each period.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable

Timeline
3mo left

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Feb 2025Sep 2026

First Submitted

Initial submission to the registry

November 26, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 5, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

February 26, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

March 10, 2025

Status Verified

March 1, 2025

Enrollment Period

1.5 years

First QC Date

November 26, 2024

Last Update Submit

March 5, 2025

Conditions

Keywords

high frequency oscillationvolume targeted ventilationnewborn infant

Outcome Measures

Primary Outcomes (1)

  • The change in the Resistive Index (RI) that will be measured on term born infants using the anterior cerebral artery Doppler on cranial ultrasound

    Through study completion, an average of 18 months

Secondary Outcomes (1)

  • The change in cardiac output that will be assessed with bedside ECHO in all infants

    Through study completion, an average of 18 months

Study Arms (2)

High frequency oscillation at the settings applied prior to the study

ACTIVE COMPARATOR
Other: HFOV at the settings applied prior to the study

High frequency oscillation with volume targeted ventilation

ACTIVE COMPARATOR
Other: HFO&VTV at targeted tidal volumes of 1.5, 2.0 and 2.5 ml/kg in random order

Interventions

HFO\&VTV at targeted tidal volumes of 1.5, 2.0 and 2.5 ml/kg in random order

High frequency oscillation with volume targeted ventilation

HFOV at the settings applied prior to the study

High frequency oscillation at the settings applied prior to the study

Eligibility Criteria

Age22 Weeks - 1 Year
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Newborn infants of any gestation receiving high frequency oscillatory ventilation

You may not qualify if:

  • Infants with known intracerebral pathology (stroke, hydrocephalus, intracerebral hemorrhage, severe hypoxic ischemic encephalopathy).
  • Infants with congenital cardiac abnormalities.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King's College Hospital

London, S£5 9RS, United Kingdom

RECRUITING

Related Publications (4)

  • Camfferman FA, de Goederen R, Govaert P, Dudink J, van Bel F, Pellicer A, Cools F; eurUS.brain group. Diagnostic and predictive value of Doppler ultrasound for evaluation of the brain circulation in preterm infants: a systematic review. Pediatr Res. 2020 Mar;87(Suppl 1):50-58. doi: 10.1038/s41390-020-0777-x.

    PMID: 32218536BACKGROUND
  • Tuzun F, Deliloglu B, Cengiz MM, Iscan B, Duman N, Ozkan H. Volume Guarantee High-Frequency Oscillatory Ventilation in Preterm Infants With RDS: Tidal Volume and DCO2 Levels for Optimal Ventilation Using Open-Lung Strategies. Front Pediatr. 2020 Mar 24;8:105. doi: 10.3389/fped.2020.00105. eCollection 2020.

    PMID: 32266185BACKGROUND
  • Iscan B, Duman N, Tuzun F, Kumral A, Ozkan H. Impact of Volume Guarantee on High-Frequency Oscillatory Ventilation in Preterm Infants: A Randomized Crossover Clinical Trial. Neonatology. 2015;108(4):277-82. doi: 10.1159/000437204. Epub 2015 Sep 1.

    PMID: 26330156BACKGROUND
  • Kaltsogianni O, Nanjundappa M, Okoye G, Greenough A, Dassios T. Effect of different targeted tidal volumes during high-frequency oscillation with volume-targeted ventilation on cerebral blood flow velocity and cardiac output: study protocol for a randomised crossover study. Trials. 2025 Oct 22;26(1):427. doi: 10.1186/s13063-025-09179-w.

Study Officials

  • Theodore Dassios, Professor

    King's College Hospital NHS Trust

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ourania Kaltsogianni, MSc

CONTACT

Theodore Dassios

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 26, 2024

First Posted

December 5, 2024

Study Start

February 26, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

March 10, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations